X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (167) 167
animals (115) 115
humans (70) 70
male (64) 64
mice (53) 53
lanosterol (52) 52
female (51) 51
cholesterol (49) 49
biochemistry & molecular biology (46) 46
lanosterol - analogs & derivatives (44) 44
pharmacology & pharmacy (43) 43
rats (37) 37
cholesterol - biosynthesis (36) 36
lanosterol - pharmacology (30) 30
lanosterol - metabolism (29) 29
biosynthesis (26) 26
analysis (23) 23
sterols (23) 23
chemistry, medicinal (21) 21
physiological aspects (20) 20
cholesterol - metabolism (19) 19
in-vitro (19) 19
antifungal agents - pharmacology (18) 18
cells (18) 18
lanosterol 14-alpha-demethylase (18) 18
metabolism (17) 17
cholesterol - blood (16) 16
endocrinology & metabolism (16) 16
gene expression (16) 16
hmg-coa reductase (16) 16
lipids (16) 16
rodents (16) 16
candida-albicans (15) 15
lanosterol - therapeutic use (15) 15
liver (15) 15
rats, sprague-dawley (15) 15
research (15) 15
enzymes (14) 14
fungi (14) 14
lanosterol - administration & dosage (14) 14
proteins (14) 14
antifungal activity (13) 13
article (13) 13
cyp51 (13) 13
dose-response relationship, drug (13) 13
fluconazole (13) 13
inhibitors (13) 13
lanosterol - chemistry (13) 13
lanosterol synthase (13) 13
liver - metabolism (13) 13
antifungal agents (12) 12
apoptosis (12) 12
biochemistry (12) 12
chemistry, multidisciplinary (12) 12
sterol 14-demethylase (12) 12
yeast (12) 12
adult (11) 11
antifungal agents - chemistry (11) 11
biology (11) 11
cell biology (11) 11
diet (11) 11
disease models, animal (11) 11
enzyme inhibitors - pharmacology (11) 11
genes (11) 11
inhibition (11) 11
lanosterol - analysis (11) 11
mass spectrometry (11) 11
microbial sensitivity tests (11) 11
multidisciplinary sciences (11) 11
anticholesteremic agents - pharmacology (10) 10
cell line (10) 10
cell line, tumor (10) 10
chemistry, organic (10) 10
cholesterol biosynthesis (10) 10
ergosterol (10) 10
hydroxymethylglutaryl coa reductases - metabolism (10) 10
hypercholesterolemia (10) 10
lanosterol - blood (10) 10
liver - drug effects (10) 10
medicine (10) 10
mice, inbred c57bl (10) 10
microbiology (10) 10
molecular structure (10) 10
plant sciences (10) 10
research article (10) 10
science (10) 10
chemistry (9) 9
gene-expression (9) 9
intramolecular transferases - antagonists & inhibitors (9) 9
lanosterol 14α-demethylase (9) 9
liver - enzymology (9) 9
organic chemistry (9) 9
reproductive biology (9) 9
triterpenes - pharmacology (9) 9
candida albicans - drug effects (8) 8
chemistry, analytical (8) 8
cholesterol-biosynthesis (8) 8
coenzyme-a reductase (8) 8
cytochrome p-450 enzyme system - metabolism (8) 8
growth (8) 8
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Tumor Biology, ISSN 1010-4283, 9/2015, Volume 36, Issue 9, pp. 7027 - 7034
Journal Article
Journal Article
European Journal of Pharmacology, ISSN 0014-2999, 01/2013, Volume 698, Issue 1-3, pp. 413 - 420
Inflammation underlies the development and progression of a number of skin disorders including psoriasis, atopic dermatitis and cancer. Therefore, novel... 
PKC | Inflammation | TPA | COX-2 | MAPK | Euphol | CELLS | PROTEIN-KINASE-C | CYCLOOXYGENASE-2 | ESTER-INDUCED EXPRESSION | EPSILON | TUMOR PROMOTION | ALPHA-AMYRIN | EPIDERMIS | PHARMACOLOGY & PHARMACY | NF-KAPPA-B | MOUSE SKIN | Inflammation - chemically induced | Inflammation - pathology | Tetradecanoylphorbol Acetate - adverse effects | Lanosterol - pharmacology | Male | Lanosterol - analogs & derivatives | Extracellular Signal-Regulated MAP Kinases - metabolism | Skin Diseases - pathology | Anti-Inflammatory Agents, Non-Steroidal - pharmacology | Leukocytes - immunology | Inflammation - drug therapy | Protein Kinase C - metabolism | Skin Diseases - chemically induced | Edema - immunology | Lanosterol - administration & dosage | Skin Diseases - drug therapy | Skin Diseases - immunology | Edema - drug therapy | Inflammation - immunology | Enzyme Activation - drug effects | Lanosterol - therapeutic use | Up-Regulation - drug effects | Animals | MAP Kinase Signaling System - drug effects | Mitogen-Activated Protein Kinase 3 - metabolism | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Anti-Inflammatory Agents, Non-Steroidal - administration & dosage | Cyclooxygenase 2 - metabolism | Leukocytes - drug effects | Mice | Edema - chemically induced | Administration, Topical | Edema - pathology | Mitogen-Activated Protein Kinase 1 - metabolism | Care and treatment | Psoriasis | Anti-inflammatory drugs | Isoenzymes | Atopic dermatitis | Skin | Protein kinases | Cancer | Index Medicus
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 06/2010, Volume 54, Issue 6, pp. 2480 - 2488
Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit... 
ASPERGILLUS-FUMIGATUS | IN-VITRO | REDUCED SUSCEPTIBILITY | ANTIFUNGAL DRUGS | PROTEIN-LIGAND COMPLEXES | CANDIDA-ALBICANS | LANOSTEROL 14-ALPHA-METHYL DEMETHYLASE | ITRACONAZOLE RESISTANCE | TRYPANOSOMA-CRUZI | AEROBIC GLUCOSE FERMENTATION | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | Chagas Disease - parasitology | Cytochrome P-450 Enzyme Inhibitors | Protozoan Proteins - antagonists & inhibitors | Humans | Sterols - biosynthesis | Indoles - administration & dosage | Trypanosoma cruzi - enzymology | Aminopyridines - chemistry | Enzyme Inhibitors - administration & dosage | Enzyme Inhibitors - chemistry | Female | Indoles - pharmacology | Protozoan Proteins - chemistry | Trypanosoma cruzi - ultrastructure | Disease Models, Animal | Aminopyridines - administration & dosage | Microscopy, Electron, Transmission | Catalytic Domain | Recombinant Proteins - antagonists & inhibitors | Enzyme Inhibitors - pharmacology | Models, Molecular | Recombinant Proteins - chemistry | Antiprotozoal Agents - chemistry | Antiprotozoal Agents - pharmacology | Mice, Inbred C3H | Cytochrome P-450 Enzyme System - chemistry | Animals | Aminopyridines - pharmacology | Antiprotozoal Agents - administration & dosage | Chagas Disease - drug therapy | Trypanosoma cruzi - drug effects | Mice | Indoles - chemistry | Index Medicus | Experimental Therapeutics
Journal Article
Journal Article
Molecules, ISSN 1420-3049, 10/2016, Volume 21, Issue 10, pp. 1395 - 1395
Journal Article
Nature, ISSN 0028-0836, 07/2015, Volume 523, Issue 7562, pp. 607 - 611
The human lens is comprised largely of crystallin proteins assembled into a highly ordered, interactive macro-structure essential for lens transparency and... 
SELENITE-INDUCED CATARACTOGENESIS | MULTIDISCIPLINARY SCIENCES | MUTATION | PREVENTION | ALPHA-B-CRYSTALLIN | DOMINANT CONGENITAL CATARACT | HUMAN OXIDOSQUALENE CYCLASE | SEQUENCING DATA | CHINESE FAMILY | LENS | EXPRESSION | Crystallins - metabolism | Humans | Cataract - pathology | Molecular Sequence Data | Lanosterol - pharmacology | Male | Amyloid - chemistry | Amyloid - ultrastructure | Lens, Crystalline - pathology | Mutant Proteins - ultrastructure | Amyloid - metabolism | Protein Aggregation, Pathological - pathology | Base Sequence | Amyloid - drug effects | Adult | Female | Child | Crystallins - chemistry | Protein Aggregates - drug effects | Amino Acid Sequence | Cell Line | Crystallins - ultrastructure | Lanosterol - administration & dosage | Mutant Proteins - genetics | Lens, Crystalline - metabolism | Models, Molecular | Mutant Proteins - metabolism | Crystallins - genetics | Cataract - metabolism | Lanosterol - therapeutic use | Protein Aggregation, Pathological - drug therapy | Animals | Cataract - congenital | Pedigree | Mutant Proteins - chemistry | Dogs | Cataract - genetics | Cataract - drug therapy | Lens, Crystalline - drug effects | Proteins | Cataract | Physiological aspects | Development and progression | Genetic aspects | Research | Gene expression | Drug therapy | Cataracts | Studies | Older people | Mortality | Mutation | Cholesterol | Index Medicus
Journal Article
BMC Complementary and Alternative Medicine, ISSN 1472-6882, 10/2018, Volume 18, Issue 1, pp. 265 - 265
Background: A substantial literature supports antidiabetic properties of the lanosteryl triterpene (methyl-3 beta-hydroxylanosta-9,24-dien-21-oate, RA-3)... 
Oxidative stress | Hyperglycemia | Glucose transporter 4 | Type 1 diabetes and lanosteryl triterpene | INTEGRATIVE & COMPLEMENTARY MEDICINE | RESISTANCE | OLEANOLIC ACID | Glucose Transporter Type 4 - metabolism | Glutathione - metabolism | Humans | Diabetes Mellitus, Type 1 - metabolism | Glycogen Synthase Kinase 3 beta - genetics | Male | Lanosterol - analogs & derivatives | Plant Bark - chemistry | Plant Extracts - administration & dosage | Hypoglycemic Agents - administration & dosage | Superoxide Dismutase - metabolism | Glucose Transporter Type 4 - genetics | Signal Transduction | Lanosterol - administration & dosage | Diabetes Mellitus, Type 1 - genetics | Rats | Glycogen Synthase Kinase 3 beta - metabolism | Rats, Sprague-Dawley | Diabetes Mellitus, Type 1 - drug therapy | Catalase - metabolism | Insulin - metabolism | Animals | Anacardiaceae - chemistry | Oxidative Stress - drug effects | Blood Glucose - metabolism | Muscles | Pancreatic beta cells | Research | Interleukins | Streptozocin | Type 1 diabetes | Interleukin | Bark | Superoxide dismutase | AKT protein | Glucose | Kinases | Blood | Interleukin 6 | Antioxidants | Proteins | Catalase | Rodents | Pancreas | Glutathione | Diabetes mellitus | Superoxide | Insulin | Malondialdehyde | Skeletal muscle | Serum levels | Signaling | Morphology | Insulin resistance | Sensitivity enhancement | Index Medicus
Journal Article